CHEK2 and lobular breast carcinoma in situ: This finding may be explained by the presence of variants in the CHEK2 gene within PRS313 that correlate with the CHEK2 c.1100delC variant, a founder mutation that has been shown to be strongly associated with LCIS and ILC (29, 43), although not universally found in all studies of ILC (44).